Chemoinformaics analysis of Methylsalicylate
Molecular Weight | 152.149 | nRot | 1 |
Heavy Atom Molecular Weight | 144.085 | nRig | 7 |
Exact Molecular Weight | 152.047 | nRing | 1 |
Solubility: LogS | -2.008 | nHRing | 0 |
Solubility: LogP | 2.338 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 1 |
nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 8 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 8 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
nHA | 3 | APOL | 21.1003 |
nHD | 1 | BPOL | 10.6297 |
QED | 0.614 |
Synth | 1.462 |
Natural Product Likeliness | 0.026 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.001 |
Pgp-sub | 0.001 |
HIA | 0.006 |
CACO-2 | -4.392 |
MDCK | 0.0000298 |
BBB | 0.793 |
PPB | 0.871409 |
VDSS | 0.722 |
FU | 0.134443 |
CYP1A2-inh | 0.937 |
CYP1A2-sub | 0.835 |
CYP2c19-inh | 0.596 |
CYP2c19-sub | 0.218 |
CYP2c9-inh | 0.248 |
CYP2c9-sub | 0.875 |
CYP2d6-inh | 0.252 |
CYP2d6-sub | 0.542 |
CYP3a4-inh | 0.065 |
CYP3a4-sub | 0.225 |
CL | 12.797 |
T12 | 0.865 |
hERG | 0.017 |
Ames | 0.088 |
ROA | 0.035 |
SkinSen | 0.276 |
Carcinogencity | 0.146 |
EI | 0.988 |
Respiratory | 0.14 |
NR-Aromatase | 0.013 |
Antiviral | No |
Prediction | 0.856744 |